Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-19-000935
Filing Date
2019-11-05
Accepted
2019-11-05 12:40:44
Documents
1
Period of Report
2019-10-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6338.html 4  
1 PRIMARY DOCUMENT doc4_6338.xml 4 11575
  Complete submission text file 0001638599-19-000935.txt   13140
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIO INC. 600 MADISON AVENUE SUITE 1601 NEW YORK NY 10022
Business Address
Isett Thomas Francis 3rd (Reporting) CIK: 0001773100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 191192471